These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies. Williams WB; Wiehe K; Saunders KO; Haynes BF J Int AIDS Soc; 2021 Nov; 24 Suppl 7(Suppl 7):e25831. PubMed ID: 34806332 [TBL] [Abstract][Full Text] [Related]
3. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex. Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335 [TBL] [Abstract][Full Text] [Related]
4. Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction. Wiehe K; Saunders KO; Stalls V; Cain DW; Venkatayogi S; Martin Beem JS; Berry M; Evangelous T; Henderson R; Hora B; Xia SM; Jiang C; Newman A; Bowman C; Lu X; Bryan ME; Bal J; Sanzone A; Chen H; Eaton A; Tomai MA; Fox CB; Tam YK; Barbosa C; Bonsignori M; Muramatsu H; Alam SM; Montefiori DC; Williams WB; Pardi N; Tian M; Weissman D; Alt FW; Acharya P; Haynes BF Cell Host Microbe; 2024 May; 32(5):693-709.e7. PubMed ID: 38670093 [TBL] [Abstract][Full Text] [Related]
5. Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development. Wiehe K; Bradley T; Meyerhoff RR; Hart C; Williams WB; Easterhoff D; Faison WJ; Kepler TB; Saunders KO; Alam SM; Bonsignori M; Haynes BF Cell Host Microbe; 2018 Jun; 23(6):759-765.e6. PubMed ID: 29861171 [TBL] [Abstract][Full Text] [Related]
6. Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses. Beltran-Pavez C; Bontjer I; Gonzalez N; Pernas M; Merino-Mansilla A; Olvera A; Miro JM; Brander C; Alcami J; Sanders RW; Sanchez-Merino V; Yuste E J Virol; 2022 Jan; 96(1):e0134321. PubMed ID: 34668778 [TBL] [Abstract][Full Text] [Related]
7. Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination. Mu Z; Haynes BF; Cain DW Curr Opin Virol; 2021 Dec; 51():172-178. PubMed ID: 34742037 [TBL] [Abstract][Full Text] [Related]
8. Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies. Gao F; Bonsignori M; Liao HX; Kumar A; Xia SM; Lu X; Cai F; Hwang KK; Song H; Zhou T; Lynch RM; Alam SM; Moody MA; Ferrari G; Berrong M; Kelsoe G; Shaw GM; Hahn BH; Montefiori DC; Kamanga G; Cohen MS; Hraber P; Kwong PD; Korber BT; Mascola JR; Kepler TB; Haynes BF Cell; 2014 Jul; 158(3):481-91. PubMed ID: 25065977 [TBL] [Abstract][Full Text] [Related]
9. Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies. Verkoczy L; Alt FW; Tian M Immunol Rev; 2017 Jan; 275(1):89-107. PubMed ID: 28133799 [TBL] [Abstract][Full Text] [Related]
10. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies. Mabvakure BM; Scheepers C; Garrett N; Abdool Karim S; Williamson C; Morris L; Moore PL J Virol; 2019 Mar; 93(6):. PubMed ID: 30567996 [TBL] [Abstract][Full Text] [Related]
11. Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy? Subbaraman H; Schanz M; Trkola A Retrovirology; 2018 Jul; 15(1):52. PubMed ID: 30055627 [TBL] [Abstract][Full Text] [Related]
17. Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers. Schorcht A; van den Kerkhof TLGM; Cottrell CA; Allen JD; Torres JL; Behrens AJ; Schermer EE; Burger JA; de Taeye SW; Torrents de la Peña A; Bontjer I; Gumbs S; Ozorowski G; LaBranche CC; de Val N; Yasmeen A; Klasse PJ; Montefiori DC; Moore JP; Schuitemaker H; Crispin M; van Gils MJ; Ward AB; Sanders RW J Virol; 2020 Nov; 94(24):. PubMed ID: 32999024 [TBL] [Abstract][Full Text] [Related]
18. Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals. Martin F; Marcelino JM; Palladino C; Bártolo I; Tracana S; Moranguinho I; Gonçalves P; Mateus R; Calado R; Borrego P; Leitner T; Clemente S; Taveira N Microbiol Spectr; 2022 Dec; 10(6):e0163422. PubMed ID: 36445130 [TBL] [Abstract][Full Text] [Related]
19. Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies. Ahmed Y; Tian M; Gao Y AIDS Res Ther; 2017 Sep; 14(1):50. PubMed ID: 28893278 [TBL] [Abstract][Full Text] [Related]
20. Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1. Sather DN; Carbonetti S; Malherbe DC; Pissani F; Stuart AB; Hessell AJ; Gray MD; Mikell I; Kalams SA; Haigwood NL; Stamatatos L J Virol; 2014 Nov; 88(22):12968-81. PubMed ID: 25122781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]